These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17371544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
    Hesse C, Ginter W, Förg T, Mayer CT, Baru AM, Arnold-Schrauf C, Unger WW, Kalay H, van Kooyk Y, Berod L, Sparwasser T.
    Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ, Xu CD, Zhou T, Wu J, Lin K, Liu W, Wang XQ.
    World J Gastroenterol; 2015 Jan 07; 21(1):187-95. PubMed ID: 25574091
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction between mannosylated lipoarabinomannan and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin influences dendritic cells maturation and T cell immunity.
    Wu T, Guo S, Wang J, Li L, Xu L, Liu P, Ma S, Zhang J, Xu L, Luo Y.
    Cell Immunol; 2011 Jan 07; 272(1):94-101. PubMed ID: 22014390
    [Abstract] [Full Text] [Related]

  • 13. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I, van Vliet SJ, Nyame AK, Cummings RD, Bank CM, Appelmelk B, Geijtenbeek TB, van Kooyk Y.
    Glycobiology; 2003 Jun 07; 13(6):471-8. PubMed ID: 12626400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y, Unger WW, Fehres CM, Kalay H, García-Vallejo JJ.
    Mol Immunol; 2013 Sep 07; 55(2):143-5. PubMed ID: 23158834
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
    Moulin V, Morgan ME, Eleveld-Trancikova D, Haanen JB, Wielders E, Looman MW, Janssen RA, Figdor CG, Jansen BJ, Adema GJ.
    Cancer Gene Ther; 2012 May 07; 19(5):303-11. PubMed ID: 22361816
    [Abstract] [Full Text] [Related]

  • 20. In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses.
    Fehres CM, van Beelen AJ, Bruijns SCM, Ambrosini M, Kalay H, Bloois LV, Unger WWJ, Garcia-Vallejo JJ, Storm G, de Gruijl TD, Kooyk YV.
    J Invest Dermatol; 2015 Sep 07; 135(9):2228-2236. PubMed ID: 25885805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.